Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Heart failure studies revisit digoxin after trial data

    May 23, 2026

    EU lawmakers urge action over Iran rights conditions

    May 22, 2026

    FAO warns Hormuz closure threatens global food systems

    May 21, 2026
    Manchester ExaminerManchester Examiner
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Manchester ExaminerManchester Examiner
    Home » New Russian 3D implant aims to help throat cancer patients
    Health

    New Russian 3D implant aims to help throat cancer patients

    July 22, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Russian scientists at the National University of Science and Technology MISIS (NUST MISIS) have developed the world’s first 3D-printed laryngeal implant designed to aid recovery for cancer patients undergoing extensive throat surgeries. The new technology enables the production of customized thyroid cartilage implants for the larynx, tailored to each patient’s anatomical features. These implants are intended to surgically replace portions of the throat lost to cancer or injury, potentially accelerating recovery and improving patients’ quality of life.

    New Russian 3D implant aims to help throat cancer patients

    The research team at NUST MISIS has already produced a working prototype of the implant using advanced 3D bio-printing techniques. The process involves printing a thermoplastic polyurethane mesh that is then thermoformed to precisely match the patient’s unique anatomy. This approach ensures a close anatomical fit and enhances the integration of the implant with surrounding tissues. According to the scientists involved, this technology is not only viable for individual cases but also suitable for mass production due to its economic efficiency.

    Hyaline cartilage, which forms the structural basis of the larynx, performs vital functions including maintaining the shape of the airway, supporting surrounding organs, and serving as an anchor for muscles and ligaments involved in speech and breathing. However, this type of cartilage has a very limited capacity for self-repair because it lacks its own blood supply and relies on slow cellular regeneration. As a result, when the thyroid cartilage is damaged or removed, natural regeneration is typically not possible without medical intervention.

    Russian scientists use bioprinting to restore damaged larynx

    Laryngeal cancer patients often face such complications, particularly in advanced stages of the disease where tumors infiltrate the larynx, necessitating the removal of the thyroid cartilage. Laryngeal cancer remains one of the most prevalent forms of head and neck cancer worldwide, and surgical removal of affected tissues often leaves patients with significant functional impairments. Traditional reconstructive techniques offer limited success and frequently require multiple procedures.

    To promote successful integration with human tissue, the scientists propose coating the 3D-printed implant with biological materials that facilitate cell adhesion. This includes collagen coatings or a biocompatible polyelectrolyte complex composed of chitosan and polyglutamic acid, both of which are widely recognized in regenerative medicine for their properties in supporting cellular attachment and proliferation. The innovation offers a new avenue in reconstructive surgery, combining the precision of digital modeling with the adaptability of modern biomaterials.

    By aligning the shape and mechanical properties of the implant with the patient’s original cartilage, the technology holds the potential to restore essential functions such as breathing, swallowing, and speaking more effectively than previous methods. Researchers emphasize that this technology remains at the prototype stage but holds significant promise for clinical application in the near future. They note that further studies, including preclinical trials, will be necessary to confirm the safety and efficacy of the implants before they become available for widespread medical use. – By EuroWire News Desk.

    Related Posts

    Heart failure studies revisit digoxin after trial data

    May 23, 2026

    EU lawmakers urge action over Iran rights conditions

    May 22, 2026

    FAO warns Hormuz closure threatens global food systems

    May 21, 2026

    UNCTAD sees global growth slowing to 2.6% in 2026

    May 21, 2026

    WHO reports nearly 600 suspected Ebola cases in DRC

    May 21, 2026

    EU commits €74 million to CEPI for epidemic readiness

    May 20, 2026
    Editor's Pick

    Heart failure studies revisit digoxin after trial data

    May 23, 2026

    EU lawmakers urge action over Iran rights conditions

    May 22, 2026

    FAO warns Hormuz closure threatens global food systems

    May 21, 2026

    UNCTAD sees global growth slowing to 2.6% in 2026

    May 21, 2026

    WHO reports nearly 600 suspected Ebola cases in DRC

    May 21, 2026

    EU commits €74 million to CEPI for epidemic readiness

    May 20, 2026

    EU fertiliser plan aims to secure supply and aid farmers

    May 20, 2026

    Russia inflation slows to 5.58 percent in April

    May 18, 2026
    © 2024 Manchester Examiner | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.